A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide

Clinical trial NCT03495921 · TERMINATED

Trial details

NCT number: NCT03495921
Sponsor: Gradalis, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ewing Sarcoma Ewing Family of Tumors Ewing's Tumor Metastatic Ewing's Sarcoma Metastatic Ewing's Tumor Recurrent Rare Diseases Sarcoma Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms, Bone Tissue Neoplasms, Connective Tissue Sarcoma, Ewing

Start date: 2018-08-21
Primary completion: 2022-01-20
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.